Astragalus (Huang Qi)

Astragalus (Astragalus membranaceus) operates through multiple pharmacologic mechanisms reflecting its complex phytochemistry. The major active fractions — astragalus polysaccharides (APS), astragalosides (particularly astragaloside IV), cycloastragenol, and isoflavonoids (formononetin, calycosin) — each contribute distinct mechanisms that converge on the herb's characteristic immune, cardiovascular, metabolic, and anti-aging effects.

1. Immune modulation (primary mechanism for infectious disease prophylaxis). Astragalus polysaccharides (APS) are the dominant immune-active fraction, operating through pattern recognition receptors on innate immune cells. APS binds to Toll-Like Receptor 4 (TLR4), Dectin-1 (β-glucan receptor), complement receptor 3 (CR3), and mannose receptors on macrophages, dendritic cells, and NK cells. Downstream effects include: (a) macrophage activation — enhanced phagocytosis, increased production of TNF-α, IL-1β, IL-6, IFN-γ, and nitric oxide; (b) NK cell stimulation — increased cytotoxicity against virus-infected and tumor cells; (c) T-cell priming — enhanced T-cell proliferation, Th1/Th2 balance modulation, increased CD4+/CD8+ ratio in immunosuppressed states; (d) B-cell and antibody response support — enhanced antigen-specific antibody production; (e) dendritic cell maturation promoting adaptive immune priming; (f) cytokine network modulation — typically up-regulating in immunosuppression and potentially down-regulating excessive inflammation. This "immunomodulation rather than pure stimulation" phenotype explains both clinical benefit in infection/cancer support and paradoxical potential in autoimmune conditions.

2. Telomerase activation (cycloastragenol / TA-65 mechanism). Cycloastragenol — the aglycone of astragaloside IV — is a partial activator of the enzyme telomerase reverse transcriptase (TERT). Telomerase synthesizes the repetitive TTAGGG telomere sequences that cap chromosome ends and shorten with each cell division; telomere shortening is a hallmark of cellular aging (replicative senescence). In immune cells (particularly CD8+ T cells and NK cells), telomerase activity normally declines with age, contributing to immunosenescence — one proposed mechanism of age-related decline in pathogen defense. Cycloastragenol has been shown to modestly activate telomerase in various cell types, slow telomere shortening, and in some studies lengthen telomeres in vivo. Harley et al. 2013 and related research demonstrated in TA-65 supplementation improvements in immune cell telomere length distributions, reductions in senescent T-cell populations (CD8+CD28- cells), and improvements in several age-associated biomarkers. However, the magnitude of telomerase activation is modest compared to full telomerase expression in tumors or germ cells, and long-term human outcome data (lifespan, cancer risk modulation) remain limited.

3. Cardiovascular protection. Astragaloside IV has multiple cardioprotective mechanisms: (a) preservation of myocardial ATP during ischemia through mitochondrial protection; (b) reduction of oxidative damage in ischemia-reperfusion injury — attenuating lipid peroxidation and preserving mitochondrial membrane potential; (c) anti-apoptotic effects in cardiomyocytes — reducing cytochrome c release, caspase activation, and myocyte death after ischemia; (d) improved contractile function in heart failure models through calcium handling and β-adrenergic response modulation; (e) vasodilation and mild antihypertensive effects via nitric oxide and prostacyclin modulation; (f) anti-arrhythmic effects in some preclinical models; (g) antiplatelet and anti-thrombotic activity from isoflavonoids. These effects underlie the substantial Chinese clinical literature on astragalus in chronic heart failure, post-MI recovery, and stroke rehabilitation.

4. Renal protection (diabetic nephropathy). Astragalus has specific renoprotective effects particularly well-studied in diabetic nephropathy: (a) podocyte protection — preservation of glomerular podocyte structure and function through mechanisms including anti-apoptotic signaling and preservation of nephrin expression; (b) anti-fibrotic effects — reduction of TGF-β-driven glomerular and tubulointerstitial fibrosis; (c) reduction of proteinuria through improved glomerular basement membrane integrity; (d) anti-inflammatory effects in renal tissue; (e) reduction of oxidative stress in kidney tissue; (f) beneficial effects on RAS (renin-angiotensin system) — some overlap with ACE-inhibitor mechanism. Multiple Chinese RCTs in diabetic nephropathy show proteinuria reductions in the 30-50% range with astragalus preparations, sometimes comparable to ACE inhibitors when used alone.

5. Metabolic effects (glucose and lipid metabolism). Astragalus affects glucose/lipid metabolism through: (a) improved insulin sensitivity — enhanced insulin receptor signaling in skeletal muscle and adipose tissue; (b) reduced hepatic gluconeogenesis; (c) AMPK activation — the "metabolic master switch" also targeted by metformin; (d) PPAR-γ modulation contributing to insulin sensitization; (e) mild direct hypoglycemic effects particularly in diabetic states; (f) lipid profile improvements — reductions in total cholesterol, LDL, triglycerides in some studies. These effects support use in type 2 diabetes and metabolic syndrome, typically as adjunctive therapy rather than primary treatment.

6. Anti-fibrotic and anti-senescence effects. Beyond kidney fibrosis, astragalus has broader anti-fibrotic activity in liver, lung, and cardiac tissue. Mechanisms include TGF-β/Smad pathway modulation, reduction of myofibroblast activation, and preservation of tissue repair rather than scarring phenotype. Cycloastragenol also shows effects on cellular senescence — reducing accumulation of p16INK4a-positive senescent cells in some models, with relevance to the broader senolytic/senomorphic research landscape. Senescent cell accumulation is a hallmark of aging and contributes to chronic inflammation ("inflammaging").

7. Hepatoprotection and antioxidant effects. Astragalus protects hepatocytes against various insults through: (a) enhancement of endogenous antioxidants — superoxide dismutase, catalase, glutathione peroxidase; (b) preservation of glutathione in stressed hepatic tissue; (c) reduction of ALT/AST elevation in various hepatotoxicity models; (d) direct radical scavenging from phenolic/flavonoid components; (e) anti-inflammatory effects in liver tissue; (f) mitochondrial protection. Clinical translation includes adjunctive use in chronic hepatitis B and liver fibrosis in Chinese medicine.

8. Fatigue and "qi" effects. Astragalus reduces fatigue through several mechanisms probably relevant to its classical "qi tonic" action: (a) improved exercise endurance in preclinical swim/run models; (b) increased erythropoiesis and mild anti-anemic effects; (c) adrenal support preventing stress-induced adrenal atrophy; (d) improved mitochondrial function supporting cellular energy production; (e) reduced muscle catabolism in chronic stress/illness; (f) central nervous system effects via adenosine receptor modulation and other pathways. The classical "qi deficiency fatigue" phenotype maps reasonably well onto modern concepts of chronic fatigue, post-viral fatigue, and mitochondrial-related fatigue.

9. Cancer-adjunctive effects. In oncology integrative care, astragalus contributes through: (a) reduction of chemotherapy-induced bone marrow suppression — particularly leukopenia; (b) maintenance of NK cell and T-cell function during chemotherapy; (c) reduction of nausea, fatigue, and quality-of-life decrements during treatment; (d) potential chemosensitization in some experimental models (astragalus may actually improve chemotherapy efficacy rather than interfere); (e) anti-angiogenic effects in some preclinical models via VEGF modulation; (f) anti-tumor immune enhancement through CTL and NK cell support. The balance between immune stimulation (beneficial) and direct tumor stimulation (theoretical concern) remains an area of research — current evidence favors adjunctive use with modern cancer therapy rather than harm.

10. Antiviral activity. Astragalus shows direct and indirect antiviral effects: (a) inhibition of viral replication against several enveloped viruses including influenza, HSV, hepatitis viruses in vitro; (b) enhancement of antiviral innate immunity — type I interferon production, NK cell activity; (c) reduction of viral-induced inflammation; (d) antiviral effects in hepatitis B with some clinical data. These mechanisms underlie classical and modern use for respiratory viral infections and hepatitis management.

Astragalus (scientific name Astragalus membranaceus, also classified as Astragalus mongholicus or Astragalus propinquus; called Huang Qi / Θ╗äΦè¬ in Mandarin Chinese — literally "yellow leader" referring to the yellow interior of the root; known in Western herbalism as milk vetch root or simply astragalus root; Radix Astragali in pharmacopeial Latin) is a perennial legume in the Fabaceae family (pea family), native to northern and northeastern China, Mongolia, Korea, and Siberia. The medicinal portion is the thick, fibrous, sweet-tasting taproot of 4-7 year old plants — harvested in autumn, cleaned, sliced into distinctive long strips with yellow cortex and paler core, and dried. Two closely related species are used interchangeably in commerce: A. membranaceus (Mongolian astragalus, the dominant commercial species) and A. mongholicus (Mongolian milk vetch). The genus Astragalus contains over 3,000 species worldwide, but only these two are the medicinal Huang Qi; most other Astragalus species contain toxic swainsonine ("locoweed") and are NOT interchangeable — a critical quality-control concern.

Astragalus occupies an exceptionally prominent position in classical Chinese medicine, rivaling ginseng as one of the most important tonic herbs in the materia medica. The foundational text Shen Nong Ben Cao Jing (~200 BCE, attributed to the mythical emperor Shen Nong) — the earliest surviving Chinese herbal pharmacopeia — classifies Huang Qi in the highest "superior grade" (Σ╕èσôü shang pin) of herbs, meaning herbs considered safe for long-term use as rejuvenative tonics with minimal toxicity. Classical TCM theory ascribes astragalus the functions of tonifying the Spleen and Lung Qi (strengthening digestive and respiratory energetic function), raising yang (lifting prolapsed organs, treating fatigue), stabilizing the Exterior and Stopping Sweating (strengthening defensive qi / wei qi against pathogen invasion), generating Flesh and Expelling Pus (promoting wound healing in chronic non-healing sores), and promoting Urination and Reducing Edema (mild diuretic action in deficiency-type edema). The classical formulas built around astragalus include Yu Ping Feng San (Jade Windscreen Powder: astragalus + atractylodes + siler — the quintessential "boost your immunity" formula used for frequent colds, allergies, and weakness); Bu Zhong Yi Qi Tang (Tonify the Middle, Augment the Qi Decoction: astragalus + ginseng + atractylodes + licorice + citrus peel + cimicifuga + bupleurum + dong quai — the flagship fatigue/organ-prolapse formula); Dang Gui Bu Xue Tang (Dang Gui Blood-Tonifying Decoction: astragalus + dong quai in 5:1 ratio — paradoxically using astragalus to "generate blood" through qi→blood classical logic); and Huang Qi Jian Zhong Tang (astragalus + cinnamon + peony + licorice + ginger + jujube + malt sugar for debility and abdominal pain). This deep classical integration means astragalus is rarely used as a standalone herb in traditional practice — it's a team player supporting other tonics.

The primary bioactive compounds in astragalus span several pharmacologic classes. Astragalosides (I-VIII) are the signature cycloartane-type triterpenoid saponins, with astragaloside IV (AS-IV) being the most studied and often used as the marker compound for quality control in modern extracts. Cycloastragenol (CAG, also called "9-CAG" or "cycloastragenol aglycone") is the aglycone (sugar-free core) of astragaloside IV — when astragaloside IV is hydrolyzed, it yields cycloastragenol. Cycloastragenol is the active compound in the commercial telomerase-activating supplement TA-65 (and related products like TAT2, TA-Sciences), which claims to extend lifespan and rejuvenate aged immune cells through partial telomerase activation. Astragalus polysaccharides (APS) are complex carbohydrate chains that constitute the dominant water-soluble immunomodulatory fraction — polysaccharides are typically active through innate immune receptors (TLR4, Dectin-1, complement receptors) and stimulate macrophage, NK cell, and T-cell function. Isoflavonoids (formononetin, calycosin, calycosin-7-O-β-D-glucoside, ononin) contribute additional cardiovascular and estrogenic effects. Sucrose and other free sugars contribute to the characteristic sweet taste and to the energetics classical TCM describes. Quality extracts are typically standardized to astragalosides (0.1-0.5% for typical root extracts; up to 90%+ for purified AS-IV), or to polysaccharides (typically 40-70% polysaccharides by weight in APS-focused extracts), or to cycloastragenol content (for telomerase-focused products).

The proposed clinical applications of astragalus span: (1) immune support and respiratory infection prophylaxis — perhaps the most evidence-backed modern use, with astragalus routinely recommended during cold/flu season, for frequent respiratory infections, and for immune recovery after illness; (2) cardiovascular protection — including heart failure, ischemic heart disease, arrhythmia, and stroke recovery with substantial Chinese clinical research; (3) adjunctive cancer care — widely used in integrative oncology to reduce chemotherapy side effects, support immunity during treatment, and improve quality of life; (4) chronic kidney disease — particularly diabetic nephropathy, with multiple RCTs showing reduced proteinuria and improved renal function; (5) diabetes and insulin resistance — glucose-lowering and insulin-sensitizing effects; (6) chronic fatigue and post-viral fatigue — classical "qi deficiency" application with reasonable modern evidence; (7) anti-aging and telomerase activation — the cycloastragenol/TA-65 angle with genuinely interesting but preliminary data; (8) autoimmune conditions — complex/paradoxical (immune-stimulating yet used traditionally for immune dysregulation); (9) wound healing and tissue repair — traditional and some modern evidence for chronic wounds; and (10) fertility support — traditional use and some modern reproductive research.

Human clinical evidence is substantial, particularly from Chinese literature (though often of variable methodological quality). Key trials: Cochrane reviews of astragalus in chronic heart failure have consistently found modest clinical benefit with acceptable safety across dozens of Chinese RCTs, though recommending higher-quality confirmatory trials. Ryan et al. 2006 and multiple subsequent diabetic nephropathy RCTs show reductions in proteinuria comparable to ACE inhibitors in some comparisons. McCulloch et al. 2006 meta-analysis found astragalus-based herbal combinations in chemotherapy reduced nausea, leukopenia, and improved quality of life. Clegg et al. 2013 and Harley et al. 2013 examined the cycloastragenol supplement TA-65, finding telomerase activation effects and immune senescence markers improved. Zhang et al. 2006 examined diabetic nephropathy with standardized astragaloside IV. Chinese literature contains many small-to-medium RCTs in chronic bronchitis, immune recovery, stroke recovery, and heart failure that are difficult to evaluate systematically but collectively support moderate efficacy for the herb.

Where does astragalus fit in the therapeutic landscape? It's distinctive as: (1) a gentle, daily-use immune tonic — safer and more appropriate for long-term use than aggressive immunostimulants; (2) the signature Chinese cardiovascular herb with genuine clinical data in heart failure and ischemic disease; (3) a cornerstone of integrative oncology support — probably the single most-used herb in Chinese medical oncology adjunctive care; (4) the source material for commercial telomerase activators like TA-65; (5) a qi-deficiency specialist — its classical use case is fatigue/weakness/chronic low-grade dysfunction, not acute pathology or overstimulation states; and (6) a team player that shines in formulas rather than standalone use. It pairs classically and meaningfully with Panax ginseng (fellow Qi tonic — ginseng more "warming" and activating, astragalus more "rising" and surface-stabilizing), Reishi (shared immunomodulation, different tissue affinities), Cordyceps (classical lung support pair), Eleuthero (sometimes called "Siberian astragalus" — both stabilize against seasonal illness), Ashwagandha (adaptogen from a different tradition with different tissue tropism), Rhodiola rosea (rhodiola activates and astragalus grounds), Schisandra (both "stabilize the exterior" in TCM framework), and Licorice Root (classical adjuvant in many astragalus formulas). It does NOT pair well during acute infections in classical TCM (the "don't tonify during invasion" rule), and should be used cautiously in autoimmune conditions given immune-stimulating effects.

Safety is excellent for most users at standard doses, reflected in its "superior grade" classical classification and thousands of years of widespread culinary-medicinal use. Astragalus root is routinely added to soups, stews, and slow-cooked dishes in Northern China as a functional food ingredient. Formal toxicology studies confirm very low acute and chronic toxicity. Key considerations include: theoretical autoimmune exacerbation risk (though clinically rarely observed at typical doses), interactions with immunosuppressants (cyclosporine, tacrolimus, mycophenolate) where astragalus may reduce drug efficacy, potential interactions with anticoagulants, and the TCM admonition to avoid during active acute infections (the reasoning being that immune "attention" should focus outward rather than be redirected to internal tonification). Adulteration with other Astragalus species containing toxic swainsonine remains a quality-control concern — purchase from reputable suppliers with species authentication.

IUPAC Name

Not yet available

CAS Number

Not yet available

Molecular Formula

Not yet available

Molecular Mass

Not yet available

Unlock Dosing Protocols

Free account gets you:

• View beginner, intermediate & advanced protocols
• See weight-based dosing calculations
• Access cycle length & frequency data

2,800+ researchers already in

Unlock Research Data

Free account gets you:

• Browse PubMed study summaries
• See clinical trial phases & results
• Access mechanism of action details

2,800+ researchers already in

Get Astragalus (Huang Qi) Price Drop Alerts

Set a target price and we'll notify you when any vendor drops below it.

Related Compounds

Data Completeness

Research Credibility